EUVIMEDOntdek EUVIMED
Systematische ÜbersichtOpen access · CC BY-NC-ND 4.0

Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature

Audrey Mathieu iD, Mathilde de Grandmont, Carolina Lucena Fernandes, Elio Kechichian

Contact Dermatitis · 2024

DOI: 10.1111/cod.14500 ↗

At a glance

Systematische Übersicht in Contact Dermatitis, 2024. Written by Audrey Mathieu and 3 co-authors. Institution: Department of Dermatology, Université de Sherbrooke, Sherbrooke, Québec, Canada. Major MEDLINE topics: Drug Eruptions, Anti-Bacterial Agents. Cited 3 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Fixed drug eruption (FDE) is a cutaneous drug reaction characterised by recurrent skin lesions occurring at the same site after each exposure to a causative agent. There is currently limited evidence in the paediatric population. The objective of this systematic review is to investigate the clinical features, causative agents and management of paediatric FDE. A systematic search of the English and French literature on paediatric FDE was conducted using the Medline and Embase databases. After full‐text article review, 92 articles were included, representing a total of 233 patients. Antibiotics were the most frequent triggering agents, mainly sulfonamides (65.0% of antibiotics). Systemic symptoms were rare, and most patients only received supportive therapy. One hundred and six patients (106) performed a test to confirm the causative agent. Of these, 72.6% had oral provocation tests (OPTs) and 28.3% had patch tests. The patient's age, presence of bullous lesions and mucosal lesions were similar between tested and untested patients. It did not seem to influence the decision to perform OPTs. Paediatric FDE is a non‐severe skin drug reaction. Antibiotics were the most reported triggering agents. Drug testing, including oral provocation test, was safely performed in the paediatric population.

Subjects

MeSH terms (MEDLINE)

Drug EruptionsAnti-Bacterial AgentsHumansChildChild, PreschoolPatch TestsAdolescent

Author keywords

adverse drug reactionfixed drug eruptionpaediatric

Substances

Anti-Bacterial Agents

Authors and institutions

  • Department of Dermatology, Université de Sherbrooke, Sherbrooke, Québec, Canada.
  • Department of Dermatology, Université Laval, Québec, Québec, Canada.

ORCID profiles: Audrey Mathieu

Cite

APA

Mathieu, A., de Grandmont, M., Fernandes, C. L., & Kechichian, E. (2024). Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature. Contact Dermatitis. https://doi.org/10.1111/cod.14500

Vancouver

Mathieu A, de Grandmont M, Fernandes CL, Kechichian E. Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature. Contact Dermatitis. 2024. doi:10.1111/cod.14500

BibTeX
@article{Mathieu2024,
  author = {Mathieu, Audrey and de Grandmont, Mathilde and Fernandes, Carolina Lucena and Kechichian, Elio},
  title = {Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14500}
}
Start for free →